ProductsBack/CD19 antibody [C1C3]

CD19 antibody [C1C3]

Name: CD19 antibody [C1C3]
SKU: GTX101512_G10
Availability: BackOrder

GTX101512

ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Product group Antibodies

TargetCD19

Overview

Supplier
GeneTex
Product Name
CD19 antibody [C1C3]
Delivery Days Customer
9
Application Supplier Note
WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. FACS: 1:50-1:200. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Applications
Flow Cytometry, ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Certification
Research Use Only
Clonality
Polyclonal
Concentration
0.21 mg/ml
Conjugate
Unconjugated
Gene ID930
Target name
CD19
Target description
CD19 molecule
Target synonyms
B4, CVID3, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, T-cell surface antigen Leu-12, differentiation antigen CD19
Host
Rabbit
Isotype
IgG
Protein IDP15391
Protein Name
B-lymphocyte antigen CD19
Scientific Description
Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation. [provided by RefSeq]
Storage Instruction
-20°C or -80°C,2°C to 8°C
UNSPSC
12352203

Yasuda T, Saito Y, Ono C, et al. Generation and characterization of CD19-iCre mice as a tool for efficient and specific conditional gene targeting in B cells. Sci Rep. 2021,11(1):5524. doi: 10.1038/s41598-021-84786-6
Read this paper
Kurimoto C, Inaba H, Ariyasu H, et al. Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors. Cancer Sci. 2020,111(5):1468-1477. doi: 10.1111/cas.14363
Read this paper
Bottero V, Sadagopan S, Johnson KE, et al. Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation. J Virol. 2013,87(21):11806-20. doi: 10.1128/JVI.01920-13
Read this paper